ArticleClinical rheumatology2021

Lupus low disease activity (SLE) in patients treated with belimumab: a single-center real-life experience (2016-2019).

Morton Aaron Scheinberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.